United Therapeutics

The Problem

Dynamic market growth of United Therapeutics (UT), a publicly traded life science company, had greatly expanded the firm’s real estate portfolio. The real estate department needed expertise and additional support to effectively plan, implement, and manage their increase in real estate related projects.

The Solution

Over a period of several years, Facility Logix provided supplemental real estate expertise focusing on UT projects with significant technical and regulatory components. Facility Logix is currently providing project management services on two UT projects.

Other Projects

LB-1/PX-1

LB-1/PX-1

United Therapeutics Corporation (UT) sought to design and develop the first full service Ex Vivo Lung Perfusion (EVLP) Center in the United States. Time to market was critical for the delivery of the building for initiating US clinical trials.

Wisconsin Alumni Research Foundation

Wisconsin Alumni Research Foundation

Facility Logix worked with a local real estate provider to detail the property’s attributes and to evaluate the potential market for a buyer of the building for its highest and best use as a fill-finish site.

John Hopkins University Fast Forward

John Hopkins University Fast Forward

Johns Hopkins FastForward business accelerator program sought to understand Baltimore City, regional and statewide lab space market dynamics to guide the design of its planned 1812 Ashland incubator

United Therapeutics has worked with Facility Logix on a variety of projects. We return to them time and again as they possess a firm and current understanding of scientific and regulatory issues impacting our facilities and projects. They develop data and market driven recommendations that enable our real estate department to present economic justifications for our decision-making. Wherever we need help, Maryland, Virginia, North Carolina, Florida or Minnesota, the Facility Logix team is there for us.

Avi Halpert

Vice President–Corporate Real Estate, United Therapeutics

Let's Talk!